Exchange Traded Concepts, LLC Sarepta Therapeutics, Inc. Transaction History
Exchange Traded Concepts, LLC
- $5.43 Billion
- Q1 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 7,500 shares of SRPT stock, worth $291,525. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,500Holding current value
$291,525% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$401 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$352 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$351 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$158 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$131 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...